|
1
|
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.
|
Bipolar Disord
|
2009
|
1.90
|
|
2
|
Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
|
Pharmacol Ther
|
2005
|
1.78
|
|
3
|
Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial.
|
Psychosomatics
|
2010
|
1.60
|
|
4
|
Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
|
J Urban Health
|
2004
|
1.54
|
|
5
|
A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.
|
J Affect Disord
|
2007
|
1.11
|
|
6
|
Prairie voles as a novel model of socially facilitated excessive drinking.
|
Addict Biol
|
2011
|
1.05
|
|
7
|
Alcohol intake in prairie voles is influenced by the drinking level of a peer.
|
Alcohol Clin Exp Res
|
2011
|
1.03
|
|
8
|
Serotonin gene polymorphisms and bipolar I disorder: focus on the serotonin transporter.
|
Ann Med
|
2005
|
1.02
|
|
9
|
Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity?
|
Gen Hosp Psychiatry
|
2011
|
0.99
|
|
10
|
Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.
|
J Clin Psychiatry
|
2008
|
0.95
|
|
11
|
Predictors of pain intensity and pain functioning in patients with the hepatitis C virus.
|
Gen Hosp Psychiatry
|
2010
|
0.95
|
|
12
|
The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.
|
J Int Neuropsychol Soc
|
2009
|
0.92
|
|
13
|
Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.
|
Psychosomatics
|
2009
|
0.92
|
|
14
|
Social housing and alcohol drinking in male-female pairs of prairie voles (Microtus ochrogaster).
|
Psychopharmacology (Berl)
|
2012
|
0.92
|
|
15
|
Safety of the treatment of interferon-alpha-induced depression.
|
Psychosomatics
|
2003
|
0.88
|
|
16
|
IL28B polymorphism is associated with both side effects and clearance of hepatitis C during interferon-alpha therapy.
|
J Interferon Cytokine Res
|
2010
|
0.88
|
|
17
|
Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection.
|
Curr Opin Psychiatry
|
2009
|
0.84
|
|
18
|
Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
|
Subst Abuse Treat Prev Policy
|
2007
|
0.84
|
|
19
|
Drinking alcohol has sex-dependent effects on pair bond formation in prairie voles.
|
Proc Natl Acad Sci U S A
|
2014
|
0.81
|
|
20
|
The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia.
|
Antivir Ther
|
2010
|
0.81
|
|
21
|
Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression.
|
Pharmacol Biochem Behav
|
2012
|
0.81
|
|
22
|
The association between viral clearance and depression in patients with hepatitis C receiving interferon-alpha and ribavirin.
|
Brain Behav Immun
|
2005
|
0.80
|
|
23
|
Can rodents be used to model interferon-alpha-induced depressive symptoms?
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2006
|
0.80
|
|
24
|
Depression and antiviral response to interferon-based therapy for hepatitis C virus infection.
|
Hepatology
|
2011
|
0.79
|
|
25
|
Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patient.
|
Dig Dis Sci
|
2013
|
0.78
|
|
26
|
Cognitive enhancement in combination with 'brain repair' may be optimal for the treatment of stimulant addiction.
|
Addiction
|
2011
|
0.78
|
|
27
|
Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessment.
|
CNS Drugs
|
2005
|
0.77
|
|
28
|
Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.
|
Neuropharmacology
|
2011
|
0.77
|
|
29
|
Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.
|
J Neurovirol
|
2013
|
0.76
|
|
30
|
Hepatitis C treatment of veterans with psychiatric illness.
|
Am J Gastroenterol
|
2006
|
0.76
|
|
31
|
Novel treatment strategies for depression in patients with hepatitis C.
|
Psychosomatics
|
2010
|
0.75
|
|
32
|
Comments on the paper 'The effect of a herbal medicine (Mao-to) for the prevention of interferon-induced psychiatric complications in chronic hepatitis C: a pilot study'.
|
Hum Psychopharmacol
|
2005
|
0.75
|